Home » Influence, research and innovation to strengthen the defenses of the over 65s

Influence, research and innovation to strengthen the defenses of the over 65s

by admin

ROME (ITALPRESS) – Strengthen the defenses against influenza viruses for the over 65s and innovate to improve the protection of the “senior” population. These are the themes at the center of an online meeting promoted by Seqirus. The initiative represented an opportunity for discussion on influenza vaccines with particular reference to the most fragile segment of the population and insights into the functioning of the immune system of the over-65s, vaccination appropriateness and available innovations. “The flu virus exists, it will continue to exist and to strike”, recalled Francesco Landi, president of the Italian Society of Gerontology and Geriatrics (SIGG). “It will continue to hit the elderly hard – he continued – and in particular the most fragile, which we have always given as a priority indication for the flu vaccination. Today of course – he highlighted – we are in a pandemic situation in which we know that there is a virus which circulates, which frightens dramatically and for which we have protective attitudes “. However, for Landi, one should not think “that the flu virus is as if by magic and miraculously disappeared” and should not be distracted by “a very careful focus on the importance of vaccination against the flu virus”. “The flu – underlined Roberto Ieraci, director of the UOC Vaccinazioni Centro Vaccinazioni Internazionali Asl Roma 1 – remains a serious disease and the flu vaccines are all safe. Last year we had little circulation of flu viruses for many reasons”, he specified, listing among these also the measures of distancing and prevention linked to the pandemic. “The flu vaccination – he said – reduces complications, hospitalizations and deaths”. Ieraci explained that “influenza viruses are characterized by their genetic variability therefore every year there are modifications” and for this reason it is “necessary to reformulate the vaccine“, which every year is “slightly different”. “The value of vaccination – he added – has not only a health but also a social aspect. Protection, even indirectly, is very important”. “We consider ourselves to be at the forefront of the fight against the flu”, highlighted Maura Cambiaggi, general manager of Seqirus Italia. According to Cambiaggi “the possible persistence of the Sars-CoV-2 virus in the coming months requires that influenza vaccination also be implemented in the best possible way because it is a fundamental element that serves to reduce the pressure on the national health system. We are proud – he concluded – to collaborate with public health by making sure that our vaccines are innovative, appropriate as possible, effective, safe and that they reach the facilities on time “. Scientific research aims to provide increasingly innovative and appropriate tools to meet the needs of patients, including in the vaccination field. With this in mind, last May the European Medicines Agency granted authorization for the use in European countries of Fluad Tetra, a quadrivalent adjuvanted vaccine for the active prophylaxis of influenza in subjects over 65 years of age. The drug will be available in Italy starting from the next influenza vaccination campaign of the 2021/2022 season. (ITALPRESS). ym / sat / red 31-Mar-21 19:57

See also  Who is behind the reckless campaign against Lakjaa?!

COPYRIGHT today © breaking latest news

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy